Natera, Inc. (NTRA) stock
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30138% above fair value
$289.50+2.03 (+0.71%)
Close on Nov 18, 2026Market cap $41.73BP/E –Yield –
Natera revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Natera's revenue for the twelve months ending Jun 30, 2026 was $2.71B, up 37.8% year over year. For fiscal 2025 it was $2.31B, up 35.9% from the year before. Over ten years it grew 28.3% a year on average. The highest annual figure on record is $2.31B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.31B | +35.9% |
| FY2024 | Dec 31, 2024 | $1.70B | +56.7% |
| FY2023 | Dec 31, 2023 | $1.08B | +32.0% |
| FY2022 | Dec 31, 2022 | $820.22M | +31.1% |
| FY2021 | Dec 31, 2021 | $625.49M | +60.0% |
| FY2020 | Dec 31, 2020 | $391.01M | +29.3% |
| FY2019 | Dec 31, 2019 | $302.33M | +17.3% |
| FY2018 | Dec 31, 2018 | $257.65M | +22.9% |
| FY2017 | Dec 31, 2017 | $209.63M | -1.4% |
| FY2016 | Dec 31, 2016 | $212.51M | +11.6% |
| FY2015 | Dec 31, 2015 | $190.36M | +19.5% |
| FY2014 | Dec 31, 2014 | $159.29M | +188.7% |
| FY2013 | Dec 31, 2013 | $55.17M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $752.75M | +37.7% |
| Q1 FY2026 | Mar 31, 2026 | $696.64M | +38.8% |
| Q4 FY2025 | Dec 31, 2025 | $665.50M | +39.8% |
| Q3 FY2025 | Sep 30, 2025 | $592.18M | +34.7% |
| Q2 FY2025 | Jun 30, 2025 | $546.60M | +32.2% |
| Q1 FY2025 | Mar 31, 2025 | $501.83M | +36.5% |
| Q4 FY2024 | Dec 31, 2024 | $476.06M | +53.0% |
| Q3 FY2024 | Sep 30, 2024 | $439.76M | +63.9% |
| Q2 FY2024 | Jun 30, 2024 | $413.35M | +58.1% |
| Q1 FY2024 | Mar 31, 2024 | $367.74M | +52.1% |
| Q4 FY2023 | Dec 31, 2023 | $311.11M | +43.2% |
| Q3 FY2023 | Sep 30, 2023 | $268.31M | +27.4% |
| Q2 FY2023 | Jun 30, 2023 | $261.40M | +31.9% |
| Q1 FY2023 | Mar 31, 2023 | $241.76M | +24.5% |
| Q4 FY2022 | Dec 31, 2022 | $217.25M | +25.6% |
| Q3 FY2022 | Sep 30, 2022 | $210.64M | +33.2% |
| Q2 FY2022 | Jun 30, 2022 | $198.20M | +39.6% |
| Q1 FY2022 | Mar 31, 2022 | $194.13M | +27.5% |
| Q4 FY2021 | Dec 31, 2021 | $173.03M | +54.0% |
| Q3 FY2021 | Sep 30, 2021 | $158.12M | +61.1% |
| Q2 FY2021 | Jun 30, 2021 | $142.03M | +64.2% |
| Q1 FY2021 | Mar 31, 2021 | $152.32M | +62.0% |
| Q4 FY2020 | Dec 31, 2020 | $112.38M | +35.0% |
| Q3 FY2020 | Sep 30, 2020 | $98.14M | +26.0% |
| Q2 FY2020 | Jun 30, 2020 | $86.47M | +16.3% |
| Q1 FY2020 | Mar 31, 2020 | $94.01M | +40.7% |
| Q4 FY2019 | Dec 31, 2019 | $83.24M | +24.3% |
| Q3 FY2019 | Sep 30, 2019 | $77.91M | +19.3% |
| Q2 FY2019 | Jun 30, 2019 | $74.36M | +17.9% |
| Q1 FY2019 | Mar 31, 2019 | $66.82M | +7.2% |
| Q4 FY2018 | Dec 31, 2018 | $66.97M | +28.7% |
| Q3 FY2018 | Sep 30, 2018 | $65.28M | +16.8% |
| Q2 FY2018 | Jun 30, 2018 | $63.07M | +20.6% |
| Q1 FY2018 | Mar 31, 2018 | $62.34M | +26.2% |
| Q4 FY2017 | Dec 31, 2017 | $52.05M | +5.6% |
| Q3 FY2017 | Sep 30, 2017 | $55.91M | +3.8% |
| Q2 FY2017 | Jun 30, 2017 | $52.28M | – |
| Q1 FY2017 | Mar 31, 2017 | $49.38M | – |
| Q4 FY2016 | Dec 31, 2016 | $49.30M | – |
| Q3 FY2016 | Sep 30, 2016 | $53.89M | – |
See a number that looks wrong?